COVID-19 incidence and outcomes among patients with kidney replacement therapy.

ABSTRACT:

Background

We aimed to investigate the incidence, fatality, and associated factors in patients with hemodialysis (HD), peritoneal dialysis (PD), and kidney transplantation (KT) hospitalized for coronavirus disease 2019 (COVID-19) infection and reimbursed from the National Health Security Office (NHSO).

Methods

The retrospective cohort analysis was conducted from an electronic-claimed database, and COVID-19 vaccination status was evaluated in patients with HD, PD, and KT from January 2020 to December 2021. There were 85,305 patients reimbursed for HD, PD, and KT by the NHSO. The rates of COVID-19 infection, COVID-19 vaccination, comorbidities, fatalities, and the cost of treatment were evaluated.

Results

COVID-19 infection was observed in 1,799 of 36,982 HD cases (4.9%

SUBMITTER: Changsirikulchai S 

PROVIDER: S-EPMC10565457 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature